Lv1
14 积分 2023-10-14 加入
Integrated signalling pathways for mast-cell activation
2个月前
已完结
OP0221 LBL-047, A NOVEL AFUCOSYLATED ANTI-BDCA2/TACI FUSION PROTEIN WITH YTE MUTATION, INHIBITS THE FUNCTIONS OF BOTH pDCs AND B CELLS
2个月前
已完结
Advances in the treatment of systemic lupus erythematosus
2个月前
已完结
Impact of Half-life Extension Via YTE Modification on the Duration of Action, Efficacy, and Safety of Monoclonal Antibodies: A Systematic Literature Review
2个月前
已完结
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH
5个月前
已完结
CD303 (BDCA-2) – a potential novel target for therapy in hematologic malignancies
6个月前
已完结
New insights into antibody structure with implications for specificity, variable region restriction and isotype choice
9个月前
已完结
抗体药物LC-MS 法生物分析进展
10个月前
已完结
Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes
10个月前
已完结
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
10个月前
已完结
皖公网安备34019202002308
